Antifibrotic effects of a herbal combination regimen on hepatic fibrotic rats

Phytotherapy Research

Volumn 22, Issue 1, 2008, Pages 69-76

  Lin, Yun Lian ^a   Hsu, Yi Chao ^b,d   Chiu, Yung Tsung ^c   Huang, Yi Tsau ^b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

smooth muscle actin; Glycyrrhiza glabra; Hepatic fibrosis; Herb; Ligusticum chuanxiong; Salvia miltiorrhiza

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; COLLAGEN; DIMETHYLNITROSAMINE; GLYCYRRHIZA GLABRA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LIGUSTICUM CHUANXIONG EXTRACT; MESSENGER RNA; SALVIA MILTIORRHIZA EXTRACT; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC EFFECT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION PROFILING; GLYCYRRHIZA GLABRA; HERBAL MEDICINE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIGUSTICUM CHUANXIONG; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZATION; RAT; SALVIA MILTIORRHIZA; TREATMENT DURATION; TREATMENT OUTCOME;

ACTINS; ANIMALS; COLLAGEN; DIMETHYLNITROSAMINE; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; GLYCYRRHIZA; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER CIRRHOSIS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SALVIA MILTIORRHIZA; SILYMARIN; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

GLYCYRRHIZA GLABRA; LIGUSTICUM CHUANXIONG; RATTUS; SALVIA MILTIORRHIZA;

EID: 38549148341     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2265     Document Type: Article

References (37)

1. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115: 209-218.
2. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. 1997. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26: 643-649.
3. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
4. Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. 2006. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J Biomed Sci 13: 403-418.
5. Friedman SL. 2003. Liver fibrosis - from bench to bedside. J Hepatol 38: S38-S53.
6. Friedman SL. 2004. Mechanism of disease: mechanism of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1: 98-105.
7. Friedman SL, Bansal MB. 2006. Reversal of hepatic fibrosis - Fact or fantasy? Hepatology 43: S82-S88.
8. Gebhardt R. 2002. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 68: 289-296.
9. Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT. 2007. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J Gastroenterol Hepatol 22: 99-111.
10. Hsu YC, Chiu YT, Lee CY, Lin YL, Huang YT. 2004. Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats. J Biomed Sci 12: 408-417.
11. Hsu YC, Lin YL, Chiu YT, Shiao MS, Lee CY, Huang YT. 2005. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. J Biomed Sci 12: 185-195.
12. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. 2002. Mechanisms of hepatotoxicity. Toxicol Sci 65: 166-176.
13. Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. 1987. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5: 174-181.
14. Jia JD, Bauer M, Cho JJ et al. 2001. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol 35: 392-398.
15. Kitamura Y, Ninomiya H. 2003. Smad expression of hepatic stellate cells in liver cirrhosis in vivo and hepatic stellate cell line in vitro. Pathol Int 53: 18-26.
16. Kumada H. 2002. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 62: 94-100.
17. Lin YL, Lee TF, Huang YJ, Huang YT. 2006a. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells. J Gastroenterol Hepatol 21: 1257-1265.
18. Lin YL, Wu CH, Luo MH et al. 2006b. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol 105: 215-222.
19. Lopez-De Leon A, Rojkind M. 1985. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33: 737-743.
20. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. 2005. Hepatic fibrosis: molecular mechanism and drug targets. Ann Rev Pharmacol Toxicol 45: 605-628.
21. Nan JX, Park EJ, Kang HC, Park PH, Kim JY, Sohn DH. 2001. Anti-fibrotic effects of a hot-water extract from Salvia miltiorrhiza roots on liver fibrosis induced by biliary obstruction in rats. J Pharm Pharmacol 53: 197-204.
22. Orlent H, Hansen BE, Willems M et al. 2006. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial. J Hepatol 45: 539-546.
23. Parola M, Robino G. 2001. Oxidative stress-related molecules and liver fibrosis. J Hepatol 35: 297-306.
24. Parsons CJ, Bradford BU, Pan CQ et al. 2004. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 40: 1106-1115.
25. Pinzani M, Marra F. 2001. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 21: 397-416.
26. Poli G. 2000. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21: 49-98.
27. Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K. 2003. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-deficient diet. J Hepatol 38: 762-769.
28. Saller R, Meier R, Brignoli R. 2001. The use of silymarin in the treatment of liver diseases. Drugs 61: 2035-2063.
29. Scheuer PJ. 1991. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374.
30. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. 1999. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30: 1099-1104.
31. Seeff LB, Lindsay KL, Bacon B, Kresina TF, Hoofnagle JH. 2001. Complementary and alternative medicine in chronic liver disease. Hepatology 34: 595-603.
32. Shiba M, Shimizu I, Yasuda M, Li K, Ito S. 1998. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 18: 196-204.
33. Shimizu I, Ma YR, Mizobuchi Y et al. 1999. Effects of Shosaiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160.
34. van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW. 1998. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Alim Pharmacol Ther 12: 199-205.
35. Wasser S, Sian-Ho JM, Ang HK, Tan CEL. 1998. Salvia miltiorrhiz reduced experimentally-induced hepatic fibrosis in rats. J Hepatol 29: 760-771.
36. 4-plus ethanol-induced liver cirrhosis in rats. Liver 18: 180-185.
37. Zhao JF, Liu CH, Hu YY, Xu LM, Liu P, Liu C. 2004. Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells. Hepatobiliary Pancreat Dis Int 3: 102-105.